Breaking News Instant updates and real-time market news.

DRI

Darden

$61.36

0.04 (0.07%)

07:00
10/04/16
10/04
07:00
10/04/16
07:00

Darden reports Q1 EPS 88c, consensus 82c

Reports Q1 revenue $1.71B, consensus $1.72B.

  • 04

    Oct

  • 02

    Nov

DRI Darden
$61.36

0.04 (0.07%)

07/13/16
WELS
07/13/16
DOWNGRADE
WELS
Market Perform
Darden downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jeff Farmer downgraded Darden Restaurants to Market Perform citing accelerating casual dining segment same-same-store declines in June. The analyst expects a diminished rate of upward earnings revision in coming quarters. He cut his price target range for the shares to $66-$70 from $70-$74.
07/26/16
STFL
07/26/16
DOWNGRADE
STFL
Sell
Darden downgraded to Sell from Hold at Stifel
Stifel analyst Paul Westra downgraded Darden based on the firm's belief that the U.S. economy will probably enter a recession within nine months. As a result, the firm now expects two year industrywide comps to come in at 0.5% in the first half of 2018, versus the consensus outlook of 1.75%, Westra stated. The analyst says that Darden's Olve Garden and Longhorn brands are already seeing weak demand, while the company lacks "brand agility" amid "fierce competition." Target $53.
08/22/16
ADAM
08/22/16
INITIATION
Target $74
ADAM
Buy
Darden initiated with a Buy at Canaccord
Canaccord analyst Lynne Collier initiated coverage on the Restaurant industry with an overall cautious outlook, saying that being selective is key. The analyst started coverage of Darden with a Buy rating and $74 price target, making it one of only four Buy rated stocks among fifteen that were initiated.
09/06/16
OPCO
09/06/16
NO CHANGE
Target $70
OPCO
Outperform
Darden at a 'misplaced discount' to peers, says Oppenheimer
Oppenheimer analyst Brian Bittner believes the market has presented another Darden buying opportunity, with stock valuation sitting at a "misplaced discount" to peers. Further, the analyst believes better in-store execution, improved off-premise business and elevated brand momentum can sustain sales trends above peers. Bittner also sees limited risk to upcoming Q1 results. He reiterates an Outperform rating and $70 price target on the shares.

TODAY'S FREE FLY STORIES

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Technical Analysis
Technical View: Finish Line drops after earnings and outlook »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PANW

Palo Alto Networks

$140.06

-1.69 (-1.19%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Conference/Events
Palo Alto Networks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 07

    Dec

  • 11

    Dec

QCOM

Qualcomm

$52.03

0.05 (0.10%)

, NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for shares of NXP Semiconductors »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$52.03

0.05 (0.10%)

NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Sprint, T-Mobile »

Sprint up 2.6% after…

S

Sprint

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

AZN

AstraZeneca

$32.81

-0.12 (-0.36%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Upgrade
AstraZeneca rating change  »

AstraZeneca upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 08

    Nov

SXT

Sensient

$75.90

0.19 (0.25%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Initiation
Sensient initiated  »

Sensient initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

, CAR

Avis Budget

$38.08

0.16 (0.42%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

MRVL

Marvell

CAR

Avis Budget

$38.08

0.16 (0.42%)

GIS

General Mills

$51.69

-0.48 (-0.92%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

HOG

Harley-Davidson

$47.96

-0.39 (-0.81%)

JBLU

JetBlue

$18.90

-0.35 (-1.82%)

MXWL

Maxwell

$4.97

-0.155 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 05

    Oct

  • 17

    Oct

  • 08

    Nov

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
T-Mobile, Sprint close to agreeing on deal terms, Reuters reports »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

DTEGY

Deutsche Telekom

$18.36

-0.39 (-2.08%)

SFTBF

SoftBank

$81.50

-1.14 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

EADSY

Airbus

$23.07

0.78 (3.50%)

, BA

Boeing

$256.04

0.58 (0.23%)

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
Turkish Airlines mulls Airbus order following Boeing deal, Reuters reports »

Turkish Airlines has…

EADSY

Airbus

$23.07

0.78 (3.50%)

BA

Boeing

$256.04

0.58 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:28
09/22/17
09/22
07:28
09/22/17
07:28
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

07:28
09/22/17
09/22
07:28
09/22/17
07:28
Hot Stocks
Trump says greatest influence over election was 'Fake News Media' »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

07:27
09/22/17
09/22
07:27
09/22/17
07:27
Periodicals
Breaking Periodicals news story on T-Mobile, Sprint, Deutsche Telekom, SoftBank »

T-Mobile, Sprint close to…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

DTEGY

Deutsche Telekom

$18.36

-0.39 (-2.08%)

SFTBF

SoftBank

$81.50

-1.14 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

FB

Facebook

$171.11

-1.06 (-0.62%)

07:26
09/22/17
09/22
07:26
09/22/17
07:26
Hot Stocks
Trump says Russia 'hoax' now onto Facebook ads »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

07:25
09/22/17
09/22
07:25
09/22/17
07:25
General news
FX Update: »

FX Update: USD-JPY dove…

JNJ

Johnson & Johnson

$131.75

-1.47 (-1.10%)

07:24
09/22/17
09/22
07:24
09/22/17
07:24
Conference/Events
FDA PDUFA Date for Janssen Biotech, a Johnson & Johnson company, Sirukumab »

Janssen Biotech, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

KBH

KB Home

$20.78

0.07 (0.34%)

07:24
09/22/17
09/22
07:24
09/22/17
07:24
Recommendations
KB Home analyst commentary  »

KB Home forward estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

CUB

Cubic

$46.80

0.6 (1.30%)

07:23
09/22/17
09/22
07:23
09/22/17
07:23
Upgrade
Cubic rating change  »

Cubic upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.60

-0.19 (-0.29%)

07:21
09/22/17
09/22
07:21
09/22/17
07:21
Conference/Events
FDA PDUFA Date for Merck's sBLA for KEYTRUDA is September 22, 2017 »

Merck's anti-PD-1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

GOOG

Alphabet

$932.45

0.87 (0.09%)

, GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

07:21
09/22/17
09/22
07:21
09/22/17
07:21
Periodicals
Google, partners to issue refunds to advertisers over fake traffic, WSJ reports »

Google is planning to…

GOOG

Alphabet

$932.45

0.87 (0.09%)

GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

JNJ

Johnson & Johnson

$131.75

-1.47 (-1.10%)

07:21
09/22/17
09/22
07:21
09/22/17
07:21
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:18
09/22/17
09/22
07:18
09/22/17
07:18
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$141.72

-0.52 (-0.37%)

07:17
09/22/17
09/22
07:17
09/22/17
07:17
Recommendations
MasterCard analyst commentary  »

MasterCard price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BP

BP

$37.70

0.47 (1.26%)

, SLB

Schlumberger

$68.09

0.47 (0.70%)

07:17
09/22/17
09/22
07:17
09/22/17
07:17
Conference/Events
Federal Reserve Banks of Dallas and Kansas City hold a conference »

2017 Energy Conference:…

BP

BP

$37.70

0.47 (1.26%)

SLB

Schlumberger

$68.09

0.47 (0.70%)

GS

Goldman Sachs

$231.29

1.5 (0.65%)

PAA

Plains All American

$21.72

-0.33 (-1.50%)

CLR

Continental Resources

$37.66

-0.15 (-0.40%)

CHK

Chesapeake

$4.17

-0.02 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 08

    Nov

GOOG

Alphabet

$932.45

0.87 (0.09%)

, GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

07:14
09/22/17
09/22
07:14
09/22/17
07:14
Periodicals
Google had planned a multimillion Garden Bridge donation, FT says »

Google (GOOG, GOOGL) was…

GOOG

Alphabet

$932.45

0.87 (0.09%)

GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

AAPL

Apple

$153.39

-2.68 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

VCRA

Vocera

$29.59

0.42 (1.44%)

07:12
09/22/17
09/22
07:12
09/22/17
07:12
Recommendations
Vocera analyst commentary  »

Vocera checks show…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.